Taiwan is intensifying efforts to screen and treat hepatitis C among high-risk groups including prisoners drug users and individuals with chronic diseases i ...

“We are delighted for both our partner, Takeda, and patients in Spain who will now be able to receive reimbursement for this innovative treatment. This is an important step forward in improving ...

New research, led by experts at the University of Nottingham, has found that repeated doses of paracetamol in people aged 65 ...

ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to ...

Research, led by experts at the University of Nottingham, has found that repeated doses of paracetamol in people aged 65 and ...

Weill Cornell Medicine has received a four-year, $1.4 million grant from the U.S. Department of Defense to investigate a new therapeutic approach for ...

The presentation highlights XORTX recent pioneering discoveries in the field of Autosomal Dominant Polycystic Kidney Disease ...

New research, led by experts at the University of Nottingham, has found that repeated doses of paracetamol in people aged 65 and over, can lead to an ...

TuHURA Biosciences, Inc. (Nasdaq: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies ...

Esperion to Receive an Upfront Payment and Near-Term Milestones Along with Tiered Royalties on Product Sales –– Israel-Based Commercial ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...